{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:24:54Z","timestamp":1792301094655,"version":"4.4.0"},"reference-count":97,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Gastroenterol"],"published-print":{"date-parts":[[2009]]},"DOI":"10.4103\/1319-3767.45072","type":"journal-article","created":{"date-parts":[[2009,2,26]],"date-time":"2009-02-26T03:34:27Z","timestamp":1235619267000},"page":"72","source":"Crossref","is-referenced-by-count":82,"title":["Reversal of liver fibrosis"],"prefix":"10.4103","volume":"15","author":[{"given":"MonaH","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-3767.45072-1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1042\/cs0920103","article-title":"Pathogenesis of liver fibrosis","author":"Alcolado","year":"1997","journal-title":"Clin Sci"},{"key":"key-10.4103\/1319-3767.45072-2","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.82.24.8681","article-title":"Hepatic lipocytes: The principal collagen-producing cells of normal rat liver","author":"Friedman","year":"1985","journal-title":"Proc Natl Acad Sci"},{"key":"key-10.4103\/1319-3767.45072-3","doi-asserted-by":"crossref","unstructured":"Fallowfield JA, Kendall TJ, Iredale JP, Reversal of fibrosis: No longer a pipe dream? Clin Liver Dis 2006;10:481-97.","DOI":"10.1016\/j.cld.2006.08.022"},{"key":"key-10.4103\/1319-3767.45072-4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2008-1040452","article-title":"Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins","author":"Schuppan","year":"1990","journal-title":"Semin Liver Dis"},{"key":"key-10.4103\/1319-3767.45072-5","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1074\/jbc.275.4.2247","article-title":"Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury","author":"Friedman","year":"2000","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1319-3767.45072-6","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis-from bench to bedside","author":"Friedman","year":"2003","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-7","doi-asserted-by":"crossref","unstructured":"Bataller R, North KE, Brenner DA, Genetic polymorphisms and the progression of liver fibrosis: A critical appraisal. Hepatology 2003;37:493-503.","DOI":"10.1053\/jhep.2003.50127"},{"key":"key-10.4103\/1319-3767.45072-8","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1111\/j.1440-1746.2004.03705.x","article-title":"Pathogenesis of cirrhosis","author":"Wanless","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"key-10.4103\/1319-3767.45072-9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jcp.31.5.395","article-title":"The morphology of cirrhosis: Working group sponsored by the World Health Organization","author":"Anthony","year":"1978","journal-title":"J Clin Pathol"},{"key":"key-10.4103\/1319-3767.45072-10","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/hep.1840360710","article-title":"Hepatocellular carcinoma and hepatitis C in the United States","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","article-title":"Liver fibrosis-from the bench to clinical targets","author":"Pinzani","year":"2004","journal-title":"Dig Liver Dis"},{"key":"key-10.4103\/1319-3767.45072-12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pathophys.2008.05.001","article-title":"The role of adipokines in liver fibrosis","author":"Bertolani","year":"2008","journal-title":"Pathophysiology"},{"key":"key-10.4103\/1319-3767.45072-13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/hep.20193","article-title":"Angiogenesis in chronic inflammatory liver disease","author":"Medina","year":"2004","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-14","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.2353\/ajpath.2007.060887","article-title":"Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells","author":"Novo","year":"2007","journal-title":"Am J Pathol"},{"key":"key-10.4103\/1319-3767.45072-15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2001-17554","article-title":"Cytokine receptors and signalling in hepatic stellate cells","author":"Pinzani","year":"2001","journal-title":"Sem Liv Dis"},{"key":"key-10.4103\/1319-3767.45072-16","doi-asserted-by":"crossref","unstructured":"Rosmorduc O, Wendum D, Corpechot C, Galy B, Sebbagh N, Raleigh J et al . Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary fibrosis. Am J Pathol 1999;155:1065-73","DOI":"10.1016\/S0002-9440(10)65209-1"},{"key":"key-10.4103\/1319-3767.45072-17","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","article-title":"Hypoxia - induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis","author":"Corpechot","year":"2002","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-18","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/hep.21921","article-title":"Antiangiogenic treatment with Sunitinib ameliorated inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats","author":"Tugues","year":"2007","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","author":"Parola","year":"2001","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-21","first-page":"109","article-title":"Liver fibrosis","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"key-10.4103\/1319-3767.45072-22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0168-8278(03)00480-X","article-title":"4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells","author":"Zamara","year":"2004","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-23","first-page":"272","article-title":"NADPH oxidase in the liver: Defensive, offensive, or fibrogenic?","author":"De","year":"2006","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-24","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1079\/PNS2006496","article-title":"Alcohol, oxidative stress and free radical damage","author":"Albano","year":"2006","journal-title":"Proc Nutr Soc"},{"key":"key-10.4103\/1319-3767.45072-25","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2004.03.007","article-title":"Cirrhosis reversal: A duel between dogma and myth","author":"Desmet","year":"2004","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","article-title":"Liver fibrosis-from the bench to clinical targets","author":"Pinzani","year":"2004","journal-title":"Dig Liver Dis"},{"key":"key-10.4103\/1319-3767.45072-27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.21624","article-title":"Biliary epithelial-mesenchymal transition in post transplantation recurrence of primary biliary cirrhosis","author":"Robertson","year":"2007","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-3767.45072-29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2036.2004.02071.x","article-title":"Review article: The evolving role of liver biopsy","author":"Campbell","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"key-10.4103\/1319-3767.45072-30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/hep.1840010511","article-title":"Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis","author":"Knodell","year":"1981","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-31","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: Diagnosis, grading and staging","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.510310136","article-title":"Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond","author":"Brunt","year":"2000","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-33","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1002\/hep.1840360720","article-title":"The role of liver biopsy in chronic hepatitis C","author":"Dienstag","year":"2002","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-34","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-35","first-page":"945","article-title":"Sampling error and intraobserver variability in liver biopsy in patients with chronic HCV infection","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/1319-3767.45072-36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/jhep.2003.50223","article-title":"Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?","author":"Afdhal","year":"2003","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cld.2008.03.006","article-title":"Noninvasive monitoring of hepatitis C fibrosis progression","author":"Kotlyar","year":"2008","journal-title":"Clin Liver Dis"},{"key":"key-10.4103\/1319-3767.45072-38","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: A prospective study","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"key-10.4103\/1319-3767.45072-39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatits C","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-40","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","author":"Forns","year":"2002","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-41","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: A cohort study","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-42","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jhep.2004.08.008","article-title":"Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients","author":"Patel","year":"2004","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-43","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2005.10.019","article-title":"Performance of serum marker panels for liver fibrosis in chronic hepatitis C","author":"Parkes","year":"2006","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2893.2002.00341.x","article-title":"Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: Longitudinal validation in a randomized trial","author":"Poynard","year":"2002","journal-title":"J Viral Hepat"},{"key":"key-10.4103\/1319-3767.45072-45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/jhep.2003.50319","article-title":"Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin","author":"Poynard","year":"2003","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-46","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3748\/wjg.14.3396","article-title":"Why, who and how should perform liver biopsy in chronic liver diseases","author":"Sporea","year":"2008","journal-title":"World J Gastroenterol"},{"key":"key-10.4103\/1319-3767.45072-47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-48","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: A new noninvasive method for assessment of hepatic fibrosis","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"key-10.4103\/1319-3767.45072-49","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1111\/j.1572-0241.2007.01466.x","article-title":"Fibro-test and FibroScan for the prediction of hepatitis C-related fibrosis: A systematic review of diagnostic test accuracy","author":"Shaheen","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"key-10.4103\/1319-3767.45072-50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0002-9343(70)80135-8","article-title":"Hepatic fibrosis: Correlation of biologic and morphologic investigations","author":"Popper","year":"1970","journal-title":"Am J Med"},{"key":"key-10.4103\/1319-3767.45072-51","first-page":"183","article-title":"Cirrhosis of the liver: A reversible disease?","author":"Perez-Tamayo","year":"1979","journal-title":"Pathol Ann"},{"key":"key-10.4103\/1319-3767.45072-52","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitis","author":"Dufour","year":"1997","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1319-3767.45072-53","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM200102083440604","article-title":"Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct","author":"Hammel","year":"2001","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-3767.45072-54","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-136-9-200205070-00009","article-title":"Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation","author":"Muretto","year":"2002","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1319-3767.45072-55","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/hep.20251","article-title":"Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss","author":"Dixon","year":"2004","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.surg.2003.10.003","article-title":"Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis","author":"Kral","year":"2004","journal-title":"Surgery"},{"key":"key-10.4103\/1319-3767.45072-57","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0168-8278(01)00218-5","article-title":"Decreasing fibrogenesis: An immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B","author":"Kweon","year":"2001","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-58","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C.The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"key-10.4103\/1319-3767.45072-59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-132-7-200004040-00002","article-title":"Histological improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy","author":"Shiratori","year":"2000","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/1319-3767.45072-60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0168-8278(01)00218-5","article-title":"Decreasing fibrogenesis: An immunoistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B","author":"Kweon","year":"2001","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-62","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-63","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/j.gastro.2004.03.017","article-title":"Long-term benefit of interferon alpha therapy of chronic hepatitis D: Regression of advanced hepatic fibrosis","author":"Farci","year":"2004","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-64","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.humpath.2006.07.007","article-title":"Direct and indirect evidence for the reversibility of cirrhosis","author":"Serpaggi","year":"2006","journal-title":"Hum Pathol"},{"key":"key-10.4103\/1319-3767.45072-65","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.21758","article-title":"Hong Kong Liver Fibrosis Study.Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients","author":"Hui","year":"2007","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cld.2004.10.001","article-title":"Long-term management of alcoholic liver disease","author":"Wakim-Fleming","year":"2005","journal-title":"Clin Liver Dis"},{"key":"key-10.4103\/1319-3767.45072-67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.surg.2003.10.003","article-title":"Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis","author":"Kral","year":"2004","journal-title":"Surgery"},{"key":"key-10.4103\/1319-3767.45072-68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0016-5085(03)00973-9","article-title":"Reversal of cirrhosis: Evidence based medicine?","author":"Desmet","year":"2003","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-69","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","article-title":"Regression of human cirrhosis: Morphologic features and the genesis of incomplete septal cirrhosis","author":"Wanless","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"key-10.4103\/1319-3767.45072-70","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0168-8278(03)00005-9","article-title":"Milestones in liver disease: Scoring chronic hepatitis","author":"Desmet","year":"2003","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-71","unstructured":"Popper H. What are the major types of hepatic cirrhosis? In: Ingelfinger F, Relman A, Finland M, editors. Controversies in internal medicine. Philadelphia, PA: WB Saunders; 1966. p. 233-43."},{"key":"key-10.4103\/1319-3767.45072-72","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/hep.1840030607","article-title":"The Copenhagen study group for liver disease: Conversion of micronodular into macronodular cirrhosis","author":"Fauerholdt","year":"1983","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"United network for organ sharing liver disease severity score committee: Model for end-stage liver disease (MELD) and allocation of donor livers","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-74","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1542-3565(05)00535-5","article-title":"Is cirrhosis an inevitable consequence of chronic hepatitis C infection?","author":"Seef","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key-10.4103\/1319-3767.45072-75","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Non alcoholic fatty liver disease","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-3767.45072-76","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.21595","article-title":"Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis","author":"Goodman","year":"2007","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-77","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-2006-951603","article-title":"Measurement of portal pressure and its role in the management of chronic liver disease: Prognosis in Patients with Cirrhosis","author":"Bosch","year":"2006","journal-title":"Sem Liver Dis"},{"key":"key-10.4103\/1319-3767.45072-78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840050313","article-title":"Portal pressure, presence of gastroesophageal varices and variceal bleeding","author":"Garcia-Tsao","year":"1985","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-79","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpgasthep1025","article-title":"Technology insight: Noninvasive assessment of liver fibrosis by biochemical scores and elastography","author":"Pinzani","year":"2008","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"key-10.4103\/1319-3767.45072-80","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/hep.22099","article-title":"Relationship of serum markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C","author":"Fontana","year":"2008","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-81","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.21665","article-title":"Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis","author":"Vizzutti","year":"2007","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-82","first-page":"1828","article-title":"The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies","author":"Friedman","year":"1993","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-3767.45072-83","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cld.2006.08.019","article-title":"New Therapies in hepatitis C virus and chronic liver disease: Antifibrotics","author":"Rockey","year":"2006","journal-title":"Clin Liver Dis"},{"key":"key-10.4103\/1319-3767.45072-84","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1023\/A:1026601904609","article-title":"Regression of hepatic fibrosis in hepatitis C with long term interferon treatment","author":"Dufour","year":"1998","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/1319-3767.45072-85","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1319-3767.45072-86","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2004.01.003","article-title":"Liver fibrosis: From the bench to clinical targets","author":"Pinzani","year":"2004","journal-title":"Dig Liver Dis"},{"key":"key-10.4103\/1319-3767.45072-87","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1053\/jhep.2000.20243","article-title":"Mechanisms and therapy of hepatic fibrosis: Report of the AASLD single topic basic research conference","author":"Friedman","year":"2000","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-88","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/gast.1997.v113.pm9322499","article-title":"A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C","author":"Houglum","year":"1997","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-89","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.1840160426","article-title":"Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis","author":"Parola","year":"1992","journal-title":"Hepatology"},{"key":"key-10.4103\/1319-3767.45072-90","first-page":"660","article-title":"Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implications for treatment of hepatic fibrosis","author":"Rockey","year":"1994","journal-title":"J Investig Med"},{"key":"key-10.4103\/1319-3767.45072-91","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1023\/A:1022869716643","article-title":"Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis","author":"Pavanato","year":"2003","journal-title":"Dig Dis Sci"},{"key":"key-10.4103\/1319-3767.45072-92","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0168-8278(02)00307-0","article-title":"Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and\/or portal hypertension","author":"Croquet","year":"2002","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-93","doi-asserted-by":"crossref","unstructured":"Warner FJ, Lubel JS, McCaughan GW, Angus PW. Liver fibrosis: A balance of ACEs? Clin Sci (Lond) 2007;113:109-18","DOI":"10.1042\/CS20070026"},{"key":"key-10.4103\/1319-3767.45072-94","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0168-8278(01)00146-5","article-title":"Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis","author":"Paizis","year":"2001","journal-title":"J Hepatol"},{"key":"key-10.4103\/1319-3767.45072-95","doi-asserted-by":"crossref","unstructured":"Cho JJ, Hocher B, Herbst H, Jia JD, Ruehl M, Hahn EG, et al. An oral endothelin: A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis. Gastroenterology 2000;118:1169-78.","DOI":"10.1016\/S0016-5085(00)70370-2"},{"key":"key-10.4103\/1319-3767.45072-96","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/gast.2002.33666","article-title":"Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro","author":"Galli","year":"2002","journal-title":"Gastroenterology"},{"key":"key-10.4103\/1319-3767.45072-97","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/gast.2000.9365","article-title":"Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells","author":"Marra","year":"2000","journal-title":"Gastroenterology"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:28:14Z","timestamp":1786649294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-3767.45072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"alternative-id":["45072"],"URL":"https:\/\/doi.org\/10.4103\/1319-3767.45072","relation":{},"ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}